Literature DB >> 26381321

A mild case of giant axonal neuropathy without central nervous system manifestation.

Reiko Koichihara1, Takashi Saito2, Akihiko Ishiyama1, Hirofumi Komaki1, Shota Yuasa1, Yoshiaki Saito1, Eiji Nakagawa1, Kenji Sugai1, Takashi Shiihara3, Ayako Shioya4, Yuko Saito4, Yujiro Higuchi5, Akihiro Hashiguchi5, Hiroshi Takashima5, Masayuki Sasaki1.   

Abstract

An 11-year-old boy presented with progressive walking disturbances. He exhibited severe equinovarus feet that together presented with hyperreflexia of the patellar tendon and extensor plantar, resembling spastic paraplegia or upper neuron disease. He showed mild distal muscle atrophy, as well. We did not observe signs of cognitive impairment, cerebellar signs, or brain magnetic resonance imaging abnormalities. Nerve biopsy showed giant axon swellings filled with neurofilaments. Gene analysis revealed novel compound heterozygous missense mutations in the gigaxonin gene, c.808G>A (p.G270S) and c.1727C>A (p.A576E). He was diagnosed with mild giant axonal neuropathy (GAN) without apparent central nervous system involvement. Patients with classical GAN manifest their symptoms during early childhood. Mild GAN, particularly in early stages, can be misdiagnosed because of lack of typical hair features and incomplete or indistinct peripheral and central nervous system symptoms. This case is important since it can aid to identify atypical and milder clinical courses of GAN. This report widens the mild GAN clinical spectrum, alerting physicians for correct diagnosis.
Copyright © 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CNS involvement; Gigaxonin gene; Peripheral neuropathy; Pyramidal signs

Mesh:

Substances:

Year:  2015        PMID: 26381321     DOI: 10.1016/j.braindev.2015.09.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Authors:  Andoni Echaniz-Laguna; Jean-Marie Cuisset; Lucie Guyant-Marechal; Patrick Aubourg; Laurent Kremer; Naziha Baaloul; Alain Verloes; Kouider Beladgham; Jimmy Perrot; Bruno Francou; Philippe Latour
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

2.  Giant Axonal Neuropathy: Clinical, Radiological, and Genetic Features.

Authors:  Meenal Garg; Shilpa D Kulkarni; Anaita Udwadia Hegde; Margi Desai; Rafat J Sayed
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

3.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

4.  Identification of Novel Compound Heterozygous Mutations in the GAN Gene of a Chinese Patient Diagnosed With Giant Axonal Neuropathy.

Authors:  Xiaomin Xu; Xiaokai Yang; Zhongliang Su; Hai Wang; Xiaoqing Li; Congcong Sun; Wenhuan Wang; Yao Chen; Chenhui Zhang; Hongping Zhang; Fan Jin; Jiayong Zheng
Journal:  Front Neurosci       Date:  2020-02-25       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.